Recent survival trends in diffuse large B‐cell lymphoma–– Have we made any progress beyond rituximab?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent survival trends in diffuse large B‐cell lymphoma–– Have we made any progress beyond rituximab?

Published:2020-06-18 Issue:15 Volume:9 Page:5519-5525
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Epperla Narendranath¹^ORCID,Vaughn John L.²,Othus Megan³,Hallack Abrahao⁴,Costa Luciano J.⁵

Affiliation:

1. Division of Hematology The Ohio State University Columbus OH USA

2. Division of Hematology and Medical Oncology Weill Cornell Medicine New York NY USA

3. Department of Biostatistics Fred Hutchinson Cancer Research Center Seattle WA USA

4. Division of Hematology and Bone Marrow Transplantation Universidade Federal de Juiz de Fora BR USA

5. Division of Hematology and Oncology Department of Medicine University of Alabama at Birmingham Birmingham AL USA

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3237

Reference34 articles.

1. Consolidative autologous hematopoietic stem-cell transplantation in first remission for non-Hodgkin lymphoma: current indications and future perspective

2. Disease characteristics, patterns of care, and survival in very elderly patients with diffuse large B-cell lymphoma

3. Treatment Patterns and Comparative Effectiveness in Elderly Diffuse Large B-Cell Lymphoma Patients: A Surveillance, Epidemiology, and End Results-Medicare Analysis

4. Survival outcomes in the very elderly with DLBCL prior to and after the introduction of rituximab: a US population-based study

5. Choosing the relative survival method for cancer survival estimation

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma;Blood Cancer Journal;2024-09-12

2. Real-world Outcomes of Diffuse Large B-cell Lymphoma Treated with frontline R-CHOP(-like) regimens in an Asian Multi-ethnic Population;2024-09-11

3. Racial disparities in the incidence and survival outcomes in diffuse large B‐cell lymphoma in adolescents and young adults;European Journal of Haematology;2024-06-18

4. Cardiovascular mortality among patients with diffuse large B-cell lymphoma: a population-based study;Leukemia & Lymphoma;2024-06-11

5. Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands;Blood Cancer Journal;2024-01-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3